TIVA, TCI, and pediatrics: where are we and where are we going?
The current role of TIVA in children is limited because of hardware limitations, and pharmacokinetic and monitoring issues. Nonetheless, the role of TIVA in children has been increasing in the past decade, in part because of surgical and medical indications. If TIVA is to become more widely used, it must be easy and simple to set up, without serious drawbacks and without added risks. Currently, many drugs destined for use with TIVA in children are off-label, and their pharmacology is poorly understood. Such off-label designations must be resolved if TIVA is to become more widely used. At the same time, many institutions have a limited number of infusion pumps, which creates a serious bottleneck and restriction on the use of TIVA.. If a true TIVA technique is used, i.v. access must be established before induction of anesthesia, which will require a means to establish i.v. access painlessly, e.g., using a topical local anesthetic. This is not a common practice in a number of jurisdictions but must be introduced if TIVA is to expand in its scope in children. Currently, I believe that we deliver a 'partial' TIVA technique in which TIVA occasionally follows an inhalational induction but in the future when the current obstacles have been resolved, I believe that we will be able practice a true TIVA technique ubiquitously in children.
Lerman
Jerrold
J
Department of Anesthesiology, Women and Children's Hospital of Buffalo, Buffalo, NY 14222, USA. jerrold.lerman@gmail.com
D000771:Anesthesia, Intravenous / Q000295:instrumentation / Q000379:methods / Q000639:trends*; D018686:Anesthetics, Intravenous / Q000008:administration & dosage / Q000737:chemistry / Q000493:pharmacokinetics; D002648:Child; D006801:Humans; D056687:Off-Label Use; D015742:Propofol / Q000737:chemistry
D018686:Anesthetics, Intravenous; D015742:Propofol